Stopping rules in veterinary randomized controlled trials.

Greg G. Habing,J. Kaneene
DOI: https://doi.org/10.2460/javma.239.9.1197
2011-11-01
Journal of the American Veterinary Medical Association
Abstract:Vet Med Today: Reference Point 1197 R controlled trials in human and veterinary medicine are used to test an intervention against a placebo, standard treatment, or both. Phase II and phase III trials involve lengthy enrollment periods and multiple veterinary centers to apply the intervention to many study subjects. Although interim analyses and stopping rules are commonly used in human research to assess the need for the continuation of a trial, they are rarely reported for veterinary RCTs. Early stoppage of RCTs is controversial because it has been associated with implausibly large treatment effects. Nonetheless, planned interim analyses and a priori stopping rules may help to satisfy the ethical obligations of applying interventions with uncertain effects to animals. Whereas all veterinary researchers are guided by ethical considerations, clinician investigators that use privately owned animals are unique in that they must simultaneously consider obligations to both the study subjects and their owners. The focus of this report is to review the ethical considerations and applications of stopping rules in veterinary RCTs in which privately owned animals are used.
What problem does this paper attempt to address?